In 1994, pharmaceutical giant Johnson & Johnson released Risperdal, an antipsychotic drug that, over the next few years, would yield hundreds of millions of dollars for the company. It has since been determined, however, that much of those profits were due to illegal, “off-label” promotions by Johnson & Johnson and the resulting lawsuits from Risperdal’s […]
